Study Finds Some Specialized Lab Tests Pose High Risk for Patient Harm
According to an AHRQ-funded study, some specialized lab tests pose a particularly high risk for patient harm. The study, “A Prospective Tool for Risk Assessment of Sendout Testing,” appeared online March 29 in Clinica Chimica Acta and will also be published in its July 1 print issue. Sendout laboratories—specialty labs used when testing is unavailable at a primary lab—have a high risk for diagnostic errors for many reasons, including increased handoffs, manual processes and complexity associated with rare, low-volume tests. AHRQ’s Kerm Henriksen, Ph.D., is a coauthor of the article, which describes a tool designed to make specialized lab tests safer.